Loading
II
IMV Inc. Stock: price and insider trades · Canada
IMV Inc.: what insiders have been doing
IMV Inc. is a listed company. Filings by its managers are published through SEDI. The past year has been quiet: not a single insider filing for IMV Inc. The previous disclosure was published on 18 January 2023.
Our records for IMV Inc. go back to 2020, with 4 purchases and 1 sale on the open market in total.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Insider Decl.
11
Thresholds
n/a
Buy Volume
€2M
4 ops. · all time
Sell Volume
€324,869
1 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Last declaration on 18 January 2023
Declarations11 total
5,886,094 sharesCommon SharesTSXSEDI:4064865
54,900 sharesCommon SharesTSXSEDI:4064402
Common SharesTSXSEDI:4003036
100,000 shares@ CA$1.85100.0% of flowCommon SharesTSXSEDI:3780510
Canonical exit: 21 Oct 2021 (T+90)
20,000 shares@ CA$1.85100.0% of flowCommon SharesTSXSEDI:3780449
Canonical exit: 21 Oct 2021 (T+90)
Common SharesTSXSEDI:3780126
1,428,571 shares@ CA$1.75100.0% of flowCommon SharesTSXSEDI:3780128
Canonical exit: 18 Oct 2021 (T+90)
51,555 shares@ CA$2.36839.0% of flowCommon SharesTSXSEDI:3666446
15,450 shares@ CA$3.93Common SharesTSXSEDI:3651948
Canonical exit: 31 Mar 2021 (T+90)
77,475 shares@ CA$6.483100.0% of flowCommon SharesTSXSEDI:3581466
78,125 shares@ CA$2.8241.6% of flowCommon SharesTSXSEDI:3557247
11 of 11 declarations
About IMV Inc.
IMV Inc. is a company listed on the Toronto Stock Exchange, focused on developing immunotherapy treatments for cancer and infectious diseases.
